DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents

Abstract

New drugs and molecular targets are urgently needed to address the emergence and spread of drug-resistant tuberculosis. Mycobacterium tuberculosis (Mtb) inosine 5'-monophosphate dehydrogenase 2 (MtbIMPDH2) is a promising yet controversial potential target. The inhibition of MtbIMPDH2 blocks the biosynthesis of guanine nucleotides, but high concentrations of guanine can potentially rescue the bacteria. Here in this paper we describe an expansion of the structure activity relationship (SAR) for the benzoxazole series of MtbIMPDH2 inhibitors and demonstrate that minimum inhibitory concentrations (MIC) of <= 1 mu M can be achieved. The antibacterial activity of the most promising compound, 17b (Q151), is derived from the inhibition of MtbIMPDH2 as demonstrated by conditional knockdown and resistant strains. Importantly, guanine does not change the MIC of 17b, alleviating the concern that guanine salvage can protect Mtb in vivo. These findings suggest that MtbIMPDH2 is a vulnerable target for tuberculosis.

Authors:
 [1]; ORCiD logo [2];  [3];  [4];  [1];  [1];  [1];  [5];  [6];  [4]; ORCiD logo [7];  [8]; ORCiD logo [1]
  1. Brandeis Univ., Waltham, MA (United States). Dept. of Biology
  2. National Inst. of Allergy and Infectious Diseases, Bethesda, MD (United States). Tuberculosis Research Section
  3. Univ. of Cape Town, Rondebosch, Cape Town (South Africa). Dept. of Drug Discovery and Development & Inst. of Infectious Disease and Molecular Medicine, H3D Drug Discovery and Development Centre
  4. Univ. del Piemonte Orientale, Novara (Italy). Dipartimento di Scienze del Farmaco
  5. Brandeis Univ., Waltham, MA (United States). Dept. of Chemistry
  6. Univ. of Chicago, IL (United States). Center for Structural Genomics of Infectious Diseases and Dept. of Biochemistry and Molecular Biology
  7. Univ. of Cape Town (South Africa). MRC/NHLS/UCT Molecular Mycobacteriology Research Unit & DST/NRF Centre of Excellence for Biomedical TB Research, Inst. of Infectious Disease and Molecular Medicine & Dept. of Pathology
  8. Univ. of Houston, Houston, TX (United States). Dept. of Pharmacological and Pharmaceutical Sciences, College of Pharmacy
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID); South African Medical research Council (SAMRC); National Research Foundation (NRF) South Africa; U. S. Department of Health and Human Services; National Institutes of Health (NIH); USDOE
OSTI Identifier:
1466338
Grant/Contract Number:  
AC02-06CH11357; HHSN272200700058C; HHSN272201200026C
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Medicinal Chemistry
Additional Journal Information:
Journal Volume: 61; Journal Issue: 11; Journal ID: ISSN 0022-2623
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Chacko, Shibin, Boshoff, Helena I. M., Singh, Vinayak, Ferraris, Davide M., Gollapalli, Deviprasad R., Zhang, Minjia, Lawson, Ann P., Pepi, Michael J., Joachimiak, Andrzej, Rizzi, Menico, Mizrahi, Valerie, Cuny, Gregory D., and Hedstrom, Lizbeth. Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents. United States: N. p., 2018. Web. doi:10.1021/acs.jmedchem.7b01839.
Chacko, Shibin, Boshoff, Helena I. M., Singh, Vinayak, Ferraris, Davide M., Gollapalli, Deviprasad R., Zhang, Minjia, Lawson, Ann P., Pepi, Michael J., Joachimiak, Andrzej, Rizzi, Menico, Mizrahi, Valerie, Cuny, Gregory D., & Hedstrom, Lizbeth. Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents. United States. https://doi.org/10.1021/acs.jmedchem.7b01839
Chacko, Shibin, Boshoff, Helena I. M., Singh, Vinayak, Ferraris, Davide M., Gollapalli, Deviprasad R., Zhang, Minjia, Lawson, Ann P., Pepi, Michael J., Joachimiak, Andrzej, Rizzi, Menico, Mizrahi, Valerie, Cuny, Gregory D., and Hedstrom, Lizbeth. Thu . "Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents". United States. https://doi.org/10.1021/acs.jmedchem.7b01839. https://www.osti.gov/servlets/purl/1466338.
@article{osti_1466338,
title = {Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents},
author = {Chacko, Shibin and Boshoff, Helena I. M. and Singh, Vinayak and Ferraris, Davide M. and Gollapalli, Deviprasad R. and Zhang, Minjia and Lawson, Ann P. and Pepi, Michael J. and Joachimiak, Andrzej and Rizzi, Menico and Mizrahi, Valerie and Cuny, Gregory D. and Hedstrom, Lizbeth},
abstractNote = {New drugs and molecular targets are urgently needed to address the emergence and spread of drug-resistant tuberculosis. Mycobacterium tuberculosis (Mtb) inosine 5'-monophosphate dehydrogenase 2 (MtbIMPDH2) is a promising yet controversial potential target. The inhibition of MtbIMPDH2 blocks the biosynthesis of guanine nucleotides, but high concentrations of guanine can potentially rescue the bacteria. Here in this paper we describe an expansion of the structure activity relationship (SAR) for the benzoxazole series of MtbIMPDH2 inhibitors and demonstrate that minimum inhibitory concentrations (MIC) of <= 1 mu M can be achieved. The antibacterial activity of the most promising compound, 17b (Q151), is derived from the inhibition of MtbIMPDH2 as demonstrated by conditional knockdown and resistant strains. Importantly, guanine does not change the MIC of 17b, alleviating the concern that guanine salvage can protect Mtb in vivo. These findings suggest that MtbIMPDH2 is a vulnerable target for tuberculosis.},
doi = {10.1021/acs.jmedchem.7b01839},
journal = {Journal of Medicinal Chemistry},
number = 11,
volume = 61,
place = {United States},
year = {Thu May 10 00:00:00 EDT 2018},
month = {Thu May 10 00:00:00 EDT 2018}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 32 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Inosine 5′-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo
journal, April 2004

  • McLEAN, Jeremy E.; Hamaguchi, Nobuko; Belenky, Peter
  • Biochemical Journal, Vol. 379, Issue 2
  • DOI: 10.1042/bj20031585

A generic approach for the catalytic reduction of nitriles
journal, July 2003


A Regulatory Role of the Bateman Domain of IMP Dehydrogenase in Adenylate Nucleotide Biosynthesis
journal, March 2009

  • Pimkin, Maxim; Pimkina, Julia; Markham, George D.
  • Journal of Biological Chemistry, Vol. 284, Issue 12
  • DOI: 10.1074/jbc.M808541200

A Screening Pipeline for Antiparasitic Agents Targeting Cryptosporidium Inosine Monophosphate Dehydrogenase
journal, August 2010

  • Sharling, Lisa; Liu, Xiaoping; Gollapalli, Deviprasad R.
  • PLoS Neglected Tropical Diseases, Vol. 4, Issue 8
  • DOI: 10.1371/journal.pntd.0000794

Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
journal, November 2012


Synthesis, in Vitro Evaluation and Cocrystal Structure of 4-Oxo-[1]benzopyrano[4,3- c ]pyrazole Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase ( Cp IMPDH) Inhibitors
journal, December 2014

  • Sun, Zhuming; Khan, Jihan; Makowska-Grzyska, Magdalena
  • Journal of Medicinal Chemistry, Vol. 57, Issue 24
  • DOI: 10.1021/jm501527z

Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis
journal, October 2017

  • Gorla, Suresh Kumar; Zhang, Yan; Rabideau, Meaghan M.
  • Antimicrobial Agents and Chemotherapy, Vol. 61, Issue 10
  • DOI: 10.1128/AAC.00939-17

The Structural Basis of Cryptosporidium-Specific IMP Dehydrogenase Inhibitor Selectivity
journal, February 2010

  • MacPherson, Iain S.; Kirubakaran, Sivapriya; Gorla, Suresh Kumar
  • Journal of the American Chemical Society, Vol. 132, Issue 4
  • DOI: 10.1021/ja909947a

Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis
journal, January 2017


MgATP Regulates Allostery and Fiber Formation in IMPDHs
journal, June 2013


Triazole Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase
journal, August 2009

  • Maurya, Sushil K.; Gollapalli, Deviprasad R.; Kirubakaran, Shivapriya
  • Journal of Medicinal Chemistry, Vol. 52, Issue 15
  • DOI: 10.1021/jm900410u

Targeting a Prokaryotic Protein in a Eukaryotic Pathogen: Identification of Lead Compounds against Cryptosporidiosis
journal, January 2008


The Antibiotic Potential of Prokaryotic IMP Dehydrogenase Inhibitors
journal, May 2011


Phthalazinone inhibitors of inosine-5′-monophosphate dehydrogenase from Cryptosporidium parvum
journal, February 2013

  • Johnson, Corey R.; Gorla, Suresh Kumar; Kavitha, Mandapati
  • Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 4
  • DOI: 10.1016/j.bmcl.2012.12.037

Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles
journal, February 2012

  • Zhang, Yong-Kang; Plattner, Jacob J.; Freund, Yvonne R.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 3
  • DOI: 10.1016/j.bmcl.2011.12.096

Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis
journal, November 2015

  • Bloemberg, Guido V.; Keller, Peter M.; Stucki, David
  • New England Journal of Medicine, Vol. 373, Issue 20
  • DOI: 10.1056/NEJMc1505196

Genes required for mycobacterial growth defined by high density mutagenesis: Genes required for mycobacterial growth
journal, March 2003


Two Classes of Bacterial IMPDHs according to Their Quaternary Structures and Catalytic Properties
journal, February 2015


IMP Dehydrogenase: Structure, Mechanism, and Inhibition
journal, July 2009


Identification of Novel Mt-Guab2 Inhibitor Series Active against M. tuberculosis
journal, March 2012


Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen
journal, December 2016

  • Cox, Jonathan A. G.; Mugumbate, Grace; Del Peral, Laura Vela-Glez
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep38986

Crystallographic studies of two variants of Pseudomonas aeruginosa IMPDH with impaired allosteric regulation
journal, August 2015

  • Labesse, Gilles; Alexandre, Thomas; Gelin, Muriel
  • Acta Crystallographica Section D Biological Crystallography, Vol. 71, Issue 9
  • DOI: 10.1107/S1399004715013115

The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
journal, September 2016


Repurposing Cryptosporidium Inosine 5′-Monophosphate Dehydrogenase Inhibitors as Potential Antibacterial Agents
journal, June 2014

  • Mandapati, Kavitha; Gorla, Suresh Kumar; House, Amanda L.
  • ACS Medicinal Chemistry Letters, Vol. 5, Issue 8
  • DOI: 10.1021/ml500203p

UCSF Chimera?A visualization system for exploratory research and analysis
journal, January 2004

  • Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.
  • Journal of Computational Chemistry, Vol. 25, Issue 13
  • DOI: 10.1002/jcc.20084

Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH
journal, March 2012

  • Kirubakaran, Sivapriya; Gorla, Suresh Kumar; Sharling, Lisa
  • Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 5
  • DOI: 10.1016/j.bmcl.2012.01.029

Metabolic Enzyme IMPDH Is Also a Transcription Factor Regulated by Cellular State
journal, July 2012

  • Kozhevnikova, Elena N.; van der Knaap, Jan A.; Pindyurin, Alexey V.
  • Molecular Cell, Vol. 47, Issue 1
  • DOI: 10.1016/j.molcel.2012.04.030

A Novel Cofactor-binding Mode in Bacterial IMP Dehydrogenases Explains Inhibitor Selectivity
journal, January 2015

  • Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia
  • Journal of Biological Chemistry, Vol. 290, Issue 9
  • DOI: 10.1074/jbc.M114.619767

The CBS subdomain of inosine 5′-monophosphate dehydrogenase regulates purine nucleotide turnover: CBS subdomain of IMPDH
journal, February 2008


The Bare Essentials of Antibiotic Target Validation
journal, November 2016


Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase
journal, May 2013

  • Gorla, Suresh Kumar; Kavitha, Mandapati; Zhang, Minjia
  • Journal of Medicinal Chemistry, Vol. 56, Issue 10
  • DOI: 10.1021/jm400241j

Transition-Metal-Free Hydration of Nitriles Using Potassium tert -Butoxide under Anhydrous Conditions
journal, March 2015

  • Midya, Ganesh Chandra; Kapat, Ajoy; Maiti, Subhadip
  • The Journal of Organic Chemistry, Vol. 80, Issue 8
  • DOI: 10.1021/jo502752u

The dynamic determinants of reaction specificity in the IMPDH/GMPR family of (β/α) 8 barrel enzymes
journal, January 2012


Mapping the Protein Interaction Network in Methicillin-Resistant Staphylococcus aureus
journal, March 2011

  • Cherkasov, Artem; Hsing, Michael; Zoraghi, Roya
  • Journal of Proteome Research, Vol. 10, Issue 3
  • DOI: 10.1021/pr100918u

Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening
journal, July 2012


Guanine nucleotide binding to the Bateman domain mediates the allosteric inhibition of eukaryotic IMP dehydrogenases
journal, November 2015

  • Buey, Rubén M.; Ledesma-Amaro, Rodrigo; Velázquez-Campoy, Adrián
  • Nature Communications, Vol. 6, Issue 1
  • DOI: 10.1038/ncomms9923

CBS domains: structure, function, and pathology in human proteins
journal, December 2005


Loss-of-function genetic tools for animal models: cross-species and cross-platform differences
journal, October 2016

  • Housden, Benjamin E.; Muhar, Matthias; Gemberling, Matthew
  • Nature Reviews Genetics, Vol. 18, Issue 1
  • DOI: 10.1038/nrg.2016.118

Triazole-Linked Inhibitors of Inosine Monophosphate Dehydrogenase from Human and Mycobacterium tuberculosis
journal, June 2010

  • Chen, Liqiang; Wilson, Daniel J.; Xu, Yanli
  • Journal of Medicinal Chemistry, Vol. 53, Issue 12
  • DOI: 10.1021/jm100424m

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
journal, June 1998

  • Cole, S. T.; Brosch, R.; Parkhill, J.
  • Nature, Vol. 393, Issue 6685
  • DOI: 10.1038/31159

Interaction network containing conserved and essential protein complexes in Escherichia coli
journal, February 2005

  • Butland, Gareth; Peregrín-Alvarez, José Manuel; Li, Joyce
  • Nature, Vol. 433, Issue 7025
  • DOI: 10.1038/nature03239

The Complex Mechanism of Antimycobacterial Action of 5-Fluorouracil
journal, January 2015


IMP Dehydrogenase Type 1 Associates with Polyribosomes Translating Rhodopsin mRNA
journal, December 2008

  • Mortimer, Sarah E.; Xu, Dong; McGrew, Dharia
  • Journal of Biological Chemistry, Vol. 283, Issue 52
  • DOI: 10.1074/jbc.M806143200

Biochemical Analysis of the Modular Enzyme Inosine 5′-Monophosphate Dehydrogenase
journal, November 1999

  • Nimmesgern, Elmar; Black, James; Futer, Olga
  • Protein Expression and Purification, Vol. 17, Issue 2
  • DOI: 10.1006/prep.1999.1136

Identification of novel diphenyl urea inhibitors of Mt-GuaB2 active against Mycobacterium tuberculosis
journal, January 2011

  • Usha, Veeraraghavan; Gurcha, Sudagar S.; Lovering, Andrew L.
  • Microbiology, Vol. 157, Issue 1
  • DOI: 10.1099/mic.0.042549-0

Selective and Potent Urea Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase
journal, September 2012

  • Gorla, Suresh Kumar; Kavitha, Mandapati; Zhang, Minjia
  • Journal of Medicinal Chemistry, Vol. 55, Issue 17
  • DOI: 10.1021/jm3007917

Hit and lead criteria in drug discovery for infectious diseases of the developing world
journal, October 2015

  • Katsuno, Kei; Burrows, Jeremy N.; Duncan, Ken
  • Nature Reviews Drug Discovery, Vol. 14, Issue 11
  • DOI: 10.1038/nrd4683

Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
journal, October 2015


IMP Dehydrogenase: Mechanism of Action and Inhibition
journal, July 1999


Works referencing / citing this record:

Synthesis and Structure–Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH
journal, July 2019


Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screen
journal, January 2019

  • Atkinson, Benjamin N.; Steadman, David; Zhao, Yuguang
  • MedChemComm, Vol. 10, Issue 8
  • DOI: 10.1039/c9md00096h

Drug-resistance in Mycobacterium tuberculosis : where we stand
journal, January 2019


2-Pyrazol-1-yl-thiazole derivatives as novel highly potent antibacterials
journal, July 2019

  • Ivanenkov, Yan A.; Yamidanov, Renat S.; Osterman, Ilya A.
  • The Journal of Antibiotics, Vol. 72, Issue 11
  • DOI: 10.1038/s41429-019-0211-y

Inhibitors of inosine 5′-monophosphate dehydrogenase as emerging new generation antimicrobial agents
journal, January 2019

  • Juvale, Kapil; Shaik, Althaf; Kirubakaran, Sivapriya
  • MedChemComm, Vol. 10, Issue 8
  • DOI: 10.1039/c9md00179d